BOSTON SCIENTIFIC CORP — Director's Dealing 2013

Mar 1, 2013

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BOSTON SCIENTIFIC CORP (BSX)
CIK: 0000885725
Period of Report: 2013-02-27

Reporting Person: Ballinger Kevin J. (SVP & Pres, Interven Cardio)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2013-02-27	Common Stock	M	3184.0000	$0.0000	Acquired	109051.0000	Direct
2013-02-27	Common Stock	F	1070.0000	$7.3300	Disposed	107981.0000	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2013-02-27	Deferred Stock Units	$	M	3184.0000	Disposed	2017-02-27	Common Stock (3184.0000)	Direct

Footnotes

F1: Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.

F2: Includes shares acquired under the Boston Scientific Global Employee Stock Purchase Plan based upon the most current data available.

F3: Shares of common stock will be issued to the reporting person in five equal annual installments beginning on February 27, 2013, the first anniversary of the date of grant.